UNITEDHEALTH GROUP INC (UNH.DE) Stock Fundamental Analysis

FRA:UNH • US91324P1021

244.35 EUR
-0.55 (-0.22%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

UNH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. UNH has only an average score on both its financial health and profitability. UNH is quite expensive at the moment. It does show a decent growth rate. UNH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year UNH was profitable.
  • UNH had a positive operating cash flow in the past year.
  • UNH had positive earnings in each of the past 5 years.
  • UNH had a positive operating cash flow in each of the past 5 years.
UNH.DE Yearly Net Income VS EBIT VS OCF VS FCFUNH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • UNH has a Return On Assets of 3.89%. This is amongst the best in the industry. UNH outperforms 82.76% of its industry peers.
  • UNH has a better Return On Equity (12.05%) than 72.41% of its industry peers.
  • UNH has a Return On Invested Capital of 5.09%. This is comparable to the rest of the industry: UNH outperforms 58.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for UNH is above the industry average of 6.14%.
Industry RankSector Rank
ROA 3.89%
ROE 12.05%
ROIC 5.09%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.6%
ROE(5y)20.55%
ROIC(3y)8.75%
ROIC(5y)9.53%
UNH.DE Yearly ROA, ROE, ROICUNH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.69%, UNH is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
  • In the last couple of years the Profit Margin of UNH has declined.
  • UNH's Operating Margin of 4.24% is in line compared to the rest of the industry. UNH outperforms 55.17% of its industry peers.
  • UNH's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.24%
PM (TTM) 2.69%
GM N/A
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
UNH.DE Yearly Profit, Operating, Gross MarginsUNH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UNH is still creating some value.
  • The number of shares outstanding for UNH has been reduced compared to 1 year ago.
  • The number of shares outstanding for UNH has been reduced compared to 5 years ago.
  • The debt/assets ratio for UNH has been reduced compared to a year ago.
UNH.DE Yearly Shares OutstandingUNH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
UNH.DE Yearly Total Debt VS Total AssetsUNH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B

2.2 Solvency

  • The Debt to FCF ratio of UNH is 4.99, which is a neutral value as it means it would take UNH, 4.99 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of UNH (4.99) is better than 82.76% of its industry peers.
  • UNH has a Debt/Equity ratio of 0.72. This is a neutral value indicating UNH is somewhat dependend on debt financing.
  • UNH has a better Debt to Equity ratio (0.72) than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.99
Altman-Z N/A
ROIC/WACC0.62
WACC8.24%
UNH.DE Yearly LT Debt VS Equity VS FCFUNH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
UNH.DE Yearly Current Assets VS Current LiabilitesUNH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • UNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.58%.
  • Measured over the past years, UNH shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.67% on average per year.
  • The Revenue has grown by 11.81% in the past year. This is quite good.
  • UNH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.72% yearly.
EPS 1Y (TTM)-41.58%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%-69.02%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%12.31%

3.2 Future

  • Based on estimates for the next years, UNH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.30% on average per year.
  • UNH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.63% yearly.
EPS Next Y10.42%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
EPS Next 5Y18.3%
Revenue Next Year-1.43%
Revenue Next 2Y0.97%
Revenue Next 3Y2.59%
Revenue Next 5Y4.63%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UNH.DE Yearly Revenue VS EstimatesUNH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200B 400B 600B
UNH.DE Yearly EPS VS EstimatesUNH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.60, the valuation of UNH can be described as rather expensive.
  • 62.07% of the companies in the same industry are more expensive than UNH, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.99. UNH is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 15.95, the valuation of UNH can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of UNH is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of UNH to the average of the S&P500 Index (28.06), we can say UNH is valued slightly cheaper.
Industry RankSector Rank
PE 17.6
Fwd PE 15.95
UNH.DE Price Earnings VS Forward Price EarningsUNH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UNH is valued a bit more expensive than 62.07% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UNH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.55
EV/EBITDA 13.33
UNH.DE Per share dataUNH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • UNH's earnings are expected to grow with 13.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y10.59%
EPS Next 3Y13.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • UNH has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
  • UNH's Dividend Yield is rather good when compared to the industry average which is at 1.79. UNH pays more dividend than 86.21% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, UNH pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

  • The dividend of UNH is nicely growing with an annual growth rate of 12.43%!
Dividend Growth(5Y)12.43%
Div Incr Years5
Div Non Decr Years5
UNH.DE Yearly Dividends per shareUNH.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • 65.66% of the earnings are spent on dividend by UNH. This is not a sustainable payout ratio.
  • The dividend of UNH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65.66%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
UNH.DE Yearly Income VS Free CF VS DividendUNH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B
UNH.DE Dividend Payout.UNH.DE Dividend Payout, showing the Payout Ratio.UNH.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNITEDHEALTH GROUP INC

FRA:UNH (2/20/2026, 7:00:00 PM)

244.35

-0.55 (-0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-27
Earnings (Next)04-15
Inst Owners83.63%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap221.34B
Revenue(TTM)447.57B
Net Income(TTM)12.06B
Analysts75.29
Price Target324.61 (32.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend7.33
Dividend Growth(5Y)12.43%
DP65.66%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.45%
Min EPS beat(2)-0.58%
Max EPS beat(2)3.48%
EPS beat(4)1
Avg EPS beat(4)-2.3%
Min EPS beat(4)-9.92%
Max EPS beat(4)3.48%
EPS beat(8)5
Avg EPS beat(8)0.06%
EPS beat(12)9
Avg EPS beat(12)0.66%
EPS beat(16)13
Avg EPS beat(16)1.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.91%
Revenue beat(8)1
Avg Revenue beat(8)-1.05%
Revenue beat(12)5
Avg Revenue beat(12)-0.37%
Revenue beat(16)6
Avg Revenue beat(16)-0.33%
PT rev (1m)-7.54%
PT rev (3m)2.17%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)7.67%
EPS NY rev (1m)0.51%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)-3.33%
Revenue NQ rev (3m)-3.27%
Revenue NY rev (1m)-2.87%
Revenue NY rev (3m)-3.15%
Valuation
Industry RankSector Rank
PE 17.6
Fwd PE 15.95
P/S 0.58
P/FCF 16.55
P/OCF 13.45
P/B 2.6
P/tB 2.6
EV/EBITDA 13.33
EPS(TTM)13.88
EY5.68%
EPS(NY)15.32
Fwd EY6.27%
FCF(TTM)14.77
FCFY6.04%
OCF(TTM)18.17
OCFY7.44%
SpS420.4
BVpS94.01
TBVpS94.01
PEG (NY)1.69
PEG (5Y)N/A
Graham Number171.35
Profitability
Industry RankSector Rank
ROA 3.89%
ROE 12.05%
ROCE 6.25%
ROIC 5.09%
ROICexc 5.62%
ROICexgc 21.72%
OM 4.24%
PM (TTM) 2.69%
GM N/A
FCFM 3.51%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.6%
ROE(5y)20.55%
ROIC(3y)8.75%
ROIC(5y)9.53%
ROICexc(3y)9.73%
ROICexc(5y)10.65%
ROICexgc(3y)29.49%
ROICexgc(5y)31.32%
ROCE(3y)10.77%
ROCE(5y)11.72%
ROICexgc growth 3Y-15.05%
ROICexgc growth 5Y-8.06%
ROICexc growth 3Y-22.49%
ROICexc growth 5Y-14%
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.99
Debt/EBITDA 3.1
Cap/Depr 83.05%
Cap/Sales 0.81%
Interest Coverage 250
Cash Conversion 82.92%
Profit Quality 130.39%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC8.24%
ROIC/WACC0.62
Cap/Depr(3y)84.55%
Cap/Depr(5y)83.03%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.86%
Profit Quality(3y)129.12%
Profit Quality(5y)123.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.58%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%-69.02%
EPS Next Y10.42%
EPS Next 2Y10.59%
EPS Next 3Y13.39%
EPS Next 5Y18.3%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%12.31%
Revenue Next Year-1.43%
Revenue Next 2Y0.97%
Revenue Next 3Y2.59%
Revenue Next 5Y4.63%
EBIT growth 1Y-41.26%
EBIT growth 3Y-12.63%
EBIT growth 5Y-3.28%
EBIT Next Year30.68%
EBIT Next 3Y19.54%
EBIT Next 5Y16.89%
FCF growth 1Y-23.26%
FCF growth 3Y-12.42%
FCF growth 5Y-4.82%
OCF growth 1Y-19.36%
OCF growth 3Y-9.63%
OCF growth 5Y-2.7%

UNITEDHEALTH GROUP INC / UNH.DE FAQ

Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?

ChartMill assigns a fundamental rating of 4 / 10 to UNH.DE.


Can you provide the valuation status for UNITEDHEALTH GROUP INC?

ChartMill assigns a valuation rating of 3 / 10 to UNITEDHEALTH GROUP INC (UNH.DE). This can be considered as Overvalued.


Can you provide the profitability details for UNITEDHEALTH GROUP INC?

UNITEDHEALTH GROUP INC (UNH.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of UNITEDHEALTH GROUP INC (UNH.DE) stock?

The Price/Earnings (PE) ratio for UNITEDHEALTH GROUP INC (UNH.DE) is 17.6 and the Price/Book (PB) ratio is 2.6.


Is the dividend of UNITEDHEALTH GROUP INC sustainable?

The dividend rating of UNITEDHEALTH GROUP INC (UNH.DE) is 7 / 10 and the dividend payout ratio is 65.66%.